Sentence examples for excess of lifetime from inspiring English sources

Discussing some of these observations in a 2005 editorial, Andrews et al. speculated that more than half of the population may experience an episode of MD at some time during their lives [ 8], far in excess of lifetime prevalence estimates from published cross-sectional studies.

One large experiment, involving lifelong follow-up of 672 female beagles exposed to various radiation doses at different times in the prenatal, perinatal and postnatal periods [ 74] showed no overall excess of lifetime breast cancer mortality although there was increased risk of non-fatal breast cancer in the subgroup exposed to radiation in the perinatal period [ 75].

A National Academy of Sciences committee analyzed the health effects of iAs in drinking water and reported theoretical maximum-likelihood estimates of excess lifetime risk of bladder and lung cancer in the U.S. population (NRC 2001).

Different smoking habits in the general population (from which we derived our lung cancer mortality rates), compared with the cohorts (from which we derived our exposure response function) would not affect our estimates of excess lifetime mortality if the assumption of no effect modification by smoking were correct.

Soil ingestion rates used to calculate dose were determined in the aforementioned 13-day soil ingestion rate study conducted at Cold Lake [ 22]. (1) Risk = Cs × IR × CF × EF × ED BW × AT × CSF The assessment of excess lifetime cancer risk through inhalation of PAHs was conducted using Eq. 2 (from US EPA [ 32]).

It should be noted that other studies of excess lifetime cancer risk attributable to ingestion of PAHs in contaminated soil and street dust have also yielded values that can be considered negligible.

Given the many scans performed over the last several years, a reasonable estimate of excess lifetime cancers would be in the hundreds of thousands.

We used estimates of lifetime excess cancer risk as indicators that, although based on a number of simplifying assumptions, help to identify important data gaps and prioritize more detailed data collection and exposure assessment needs.

We employed a risk assessment-based approach to produce screening-level estimates of lifetime excess cancer risk for selected substances listed as known carcinogens by the International Agency for Research on Cancer.

We estimated the number of lifetime excess cancer cases due to exposure to the 17 carcinogenic PAHs [12 priority pollutant PAHs and five high-molecular-weight (302 Da) PAHs (MW 302 PAHs)] to range from 6.5 to 518 per million people for the source control period concentrations and from 12.2 to 964 per million people for the nonsource control period concentrations.

Using a point-estimate approach, we estimated the number of lifetime excess inhalation cancer cases due to exposure to the 17 carcinogenic PAHs to range from 6.5 to 518 per million people for the source control period concentrations and from 12.2 to 964 per million people for the nonsource control period concentrations.